SGO

SGO

Offline Online

The next 5 years in gynaecologic malignancies treatment #SGOmtg

570 0 Acute Lymphoblastic Leukemia
Play Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Date added (newest)

Toxicity as a Biomarker

Toxicity as a Biomarker

SGO 2016 highlights and trends #SGOmtg

SGO 2016 highlights and trends #SGOmtg

The next 5 years in gynaecologic malignancies treatment #SGOmtg

The next 5 years in gynaecologic malignancies treatment #SGOmtg

SGO Presidential address inspirational #SGOmtg

SGO Presidential address inspirational #SGOmtg

High number of uterine and BRCA mutations from study focusing on endometrial cancer patients #SGOmtg

High number of uterine and BRCA mutations from study focusing on endometrial cancer patients #SGOmtg

Future clinical trials in ovarian cancer #SGOmtg

Future clinical trials in ovarian cancer #SGOmtg

Recommendations to physicians who’s patients are concerned about their risk of ovarian cancer #SGOmtg

Recommendations to physicians who’s patients are concerned about their risk of ovarian cancer #SGOmtg

Genetic testing improves early detection of BRCA in at risk women for ovarian cancer #SGOmtg

Genetic testing improves early detection of BRCA in at risk women for ovarian cancer #SGOmtg

Genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities #SGOmtg

Genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities #SGOmtg

Genetic counseling and prophylactic measures for women at high risk for ovarian cancer #SGOmtg

Genetic counseling and prophylactic measures for women at high risk for ovarian cancer #SGOmtg

All women with ovarian cancer should undergo genomic testing for BRCA mutation #SGOmtg

All women with ovarian cancer should undergo genomic testing for BRCA mutation #SGOmtg

Preoperative staging and likelihood of R0 resection in gynecologic cancer #SGOmtg

Preoperative staging and likelihood of R0 resection in gynecologic cancer #SGOmtg

Toxicity as a Biomarker

35 0 Acute Lymphoblastic Leukemia

Toxicity as a Biomarker Frede Donkosov MD

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

SGO 2016 highlights and trends #SGOmtg

1873 0 Acute Lymphoblastic Leukemia

B.J. Rimel, MD of Cedars Sinai Medical Center discusses the SGO 2016 highlights and trends from SGO 2016.

Transcription:

I think that the array of options. For testing whether it be genetic panel testing with multiple multiple genes. Or is it a ray of immunotherapy auctions are probably the two strongest trends I see here at this meeting. There's a lot of work that remains to be done to see how that's going to play out for patients I think that clinicians and providers. And patients need to be aware of these options before we run headlong into these be aware of the risks the benefits. The potential outcomes both good and bad I think clinical trials are incredibly valuable as we start all the stuff out elements are really appreciate all the patients that devote themselves to being on a clinical trial.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

The next 5 years in gynaecologic malignancies treatment #SGOmtg

570 0 Acute Lymphoblastic Leukemia

B.J. Rimel, MD of Cedars Sinai Medical Center discusses the next 5 years in gynaecologic malignancies treatment from SGO 2016.

Transcription:

I think that we're going to continue become more multi disciplinary then we have been. Gynecologic oncology is. Expanding in the types of people that are practicing it medical oncologist being included in our society pharmacist nurse. Shares position of. Students. Our frozen residents I think it's just an incredibly expanding field and I think that that's going to be a wonderful opportunity for us to draw on the experiences of other disciplines to help better treat our.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

SGO Presidential address inspirational #SGOmtg

470 0 Acute Lymphoblastic Leukemia

B.J. Rimel, MD of Cedars Sinai Medical Center discusses the SGO Presidential address and how inspirational it was from SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

High number of uterine and BRCA mutations from study focusing on endometrial cancer patients #SGOmtg

928 0 Acute Lymphoblastic Leukemia

B.J. Rimel, MD of Cedars Sinai Medical Center discusses the high number of uterine and BRCA mutations from study focusing on endometrial cancer patients from SGO 2016.

Transcription:

There is another abstract by doctor ring that looked at and unselected cohort of individual cancer patients that have been panel tested and soon there some pretty remarkable findings from. Paper I specifically that there were urine cancers that had opposed. Surprisingly high number of mutations that were previously unknowns there there are some recommendations in their serious cancers which is really interesting more data will be very valuable and try to figure out what that means for patients.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Future clinical trials in ovarian cancer #SGOmtg

693 0 Acute Lymphoblastic Leukemia

B.J. Rimel, MD of Cedars Sinai Medical Center discusses the future clinical trials in ovarian cancer from SGO 2016.

Transcription:

In terms of future clinical trials. There we are selecting more clinical trials based on. Known genetic predispositions be RCA. The potential response to platinum potential response to part now being a sort of thing that we're looking at. So all of these panel testings are going to lead us down different pathways and so that does make us help a stratified patients for future study for clinical trials. Probably the direction I see that going on right now.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Recommendations to physicians who’s patients are concerned about their risk of ovarian cancer #SGOmtg

382 0 Acute Lymphoblastic Leukemia

Karen H. Lu, MD of MD Anderson discusses recommendations to physicians whos patients are concerned about their risk of ovarian cancer from SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Genetic testing improves early detection of BRCA in at risk women for ovarian cancer #SGOmtg

594 0 Acute Lymphoblastic Leukemia

Karen H. Lu, MD of MD Anderson discusses how genetic testing improves early detection of BRCA in at risk women for ovarian cancer from SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities #SGOmtg

253 0 Acute Lymphoblastic Leukemia

Karen H. Lu, MD of MD Anderson discusses genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities from SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Genetic counseling and prophylactic measures for women at high risk for ovarian cancer #SGOmtg

387 0 Acute Lymphoblastic Leukemia

Karen H. Lu, MD of MD Anderson discusses genetic counseling and prophylactic measures for women at high risk for ovarian cancer from SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

All women with ovarian cancer should undergo genomic testing for BRCA mutation #SGOmtg

520 0 Acute Lymphoblastic Leukemia

Karen H. Lu, MD of MD Anderson says that all women with ovarian cancer should undergo genomic testing for BRCA mutation from SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Preoperative staging and likelihood of R0 resection in gynecologic cancer #SGOmtg

494 0 Acute Lymphoblastic Leukemia

Thomas Herzog, MD of UC Health discusses preoperative staging and likelihood of R0 resection in gynecologic cancer at SGO 2016.

Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
My videos
Toxicity as a Biomarker

Toxicity as a Biomarker
Toxicity as a Biomarker Frede Donkosov MD
35 Views
7 years Ago
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
SGO 2016 highlights and trends #SGOmtg
SGO 2016 highlights and trends #SGOmtg
1,873 Views
The next 5 years in gynaecologic malignancies treatment #SGOmtg
The next 5 years in gynaecologic malignancies treatment #SGOmtg
570 Views
SGO Presidential address inspirational #SGOmtg
SGO Presidential address inspirational #SGOmtg
470 Views
High number of uterine and BRCA mutations from study focusing on endometrial cancer patients #SGOmtg
High number of uterine and BRCA mutations from study focusing on endometrial cancer patients #SGOmtg
928 Views
Future clinical trials in ovarian cancer #SGOmtg
Future clinical trials in ovarian cancer #SGOmtg
693 Views
Recommendations to physicians who’s patients are concerned about their risk of ovarian cancer #SGOmtg
Recommendations to physicians who’s patients are concerned about their risk of ovarian cancer #SGOmtg
382 Views
Genetic testing improves early detection of BRCA in at risk women for ovarian cancer #SGOmtg
Genetic testing improves early detection of BRCA in at risk women for ovarian cancer #SGOmtg
594 Views
Genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities #SGOmtg
Genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities #SGOmtg
253 Views
Genetic counseling and prophylactic measures for women at high risk for ovarian cancer #SGOmtg
Genetic counseling and prophylactic measures for women at high risk for ovarian cancer #SGOmtg
387 Views
All women with ovarian cancer should undergo genomic testing for BRCA mutation #SGOmtg
All women with ovarian cancer should undergo genomic testing for BRCA mutation #SGOmtg
520 Views
Preoperative staging and likelihood of R0 resection in gynecologic cancer #SGOmtg
Preoperative staging and likelihood of R0 resection in gynecologic cancer #SGOmtg
494 Views
Neoadjuvant regimen for patients with ovarian cancer #SGOmtg
Neoadjuvant regimen for patients with ovarian cancer #SGOmtg
432 Views
GOG-172 and the ability to modify the Armstrong regimen for greater tolerability #SGOmtg
GOG-172 and the ability to modify the Armstrong regimen for greater tolerability #SGOmtg
397 Views
Does neoadjuvant chemotherapy compromise postoperative recovery #SGOmtg
Does neoadjuvant chemotherapy compromise postoperative recovery #SGOmtg
440 Views
Age and the decision to use intraperitoneal chemotherapy in ovarian cancer #SGOmtg
Age and the decision to use intraperitoneal chemotherapy in ovarian cancer #SGOmtg
673 Views
Trabectedin improves PFS over Dacarbazine in uterine leiomyosarcoma #SGOmtg
Trabectedin improves PFS over Dacarbazine in uterine leiomyosarcoma #SGOmtg
412 Views
Trabectedin improves patients with drug resistant metastatic leiomyosarcoma #SGOmtg
Trabectedin improves patients with drug resistant metastatic leiomyosarcoma #SGOmtg
480 Views
Gynecologic cancer treatment trends for 2016 #SGOmtg
Gynecologic cancer treatment trends for 2016 #SGOmtg
1,313 Views
GOG-86P results and genetic testing among most notable data released at SGO 2016 #SGOmtg
GOG-86P results and genetic testing among most notable data released at SGO 2016 #SGOmtg
738 Views
Genomic analysis and immunotherapy are treatments to watch in gynecologic malignancies #SGOmtg
Genomic analysis and immunotherapy are treatments to watch in gynecologic malignancies #SGOmtg
438 Views
Toxicities of anti-PD-1 and anti-PD-L1 in gynecologic cancers #SGOmtg
Toxicities of anti-PD-1 and anti-PD-L1 in gynecologic cancers #SGOmtg
510 Views
The unique side effects of trabectedin #SGOmtg
The unique side effects of trabectedin #SGOmtg
346 Views
Promising immunotherapy currently under evaluation for advance gynecologic cancers #SGOmtg
Promising immunotherapy currently under evaluation for advance gynecologic cancers #SGOmtg
481 Views
PDL-1 and immune checkpoint inhibitors in endometrial cancer #SGOmtg
PDL-1 and immune checkpoint inhibitors in endometrial cancer #SGOmtg
705 Views
Loading